Search Results - "Degani, Mariam S."

Refine Results
  1. 1

    Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression by Kande, Kishor V., Kotak, Darsheen J., Degani, Mariam S., Kirsanov, Dmitry, Legin, Andrey, Devarajan, Padma V.

    Published in AAPS PharmSciTech (01-08-2017)
    “…ABSTRACT Orally disintegrating tablets (ODTs) are challenged by the need for simple technology to ensure good mechanical strength coupled with rapid…”
    Get full text
    Journal Article
  2. 2

    Tackling SARS-CoV-2: proposed targets and repurposed drugs by Joshi, Siddhi, Joshi, Maithili, Degani, Mariam S

    Published in Future medicinal chemistry (01-09-2020)
    “…The SARS-CoV-2 pandemic, declared as a global health emergency by the WHO in February 2020, has currently infected more than 6 million people with fatalities…”
    Get full text
    Journal Article
  3. 3

    A review of molecular modelling studies of dihydrofolate reductase inhibitors against opportunistic microorganisms and comprehensive evaluation of new models by Tawari, Nilesh R, Bag, Seema, Degani, Mariam S

    Published in Current pharmaceutical design (01-03-2011)
    “…Dihydrofolate reductase (DHFR) has been used as a target for antimicrobial drug discovery against a variety of pathogenic microorganisms, including…”
    Get more information
    Journal Article
  4. 4

    Design, synthesis and antimycobacterial activity of cinnamide derivatives: A molecular hybridization approach by Kakwani, Manoj D., Suryavanshi, Prashant, Ray, Muktikant, Rajan, M.G.R., Majee, Sharmila, Samad, Abdul, Devarajan, Padma, Degani, Mariam S.

    Published in Bioorganic & medicinal chemistry letters (01-04-2011)
    “…A series of cinnamide derivatives was designed as potential antimycobacterial agents using molecular hybridization approach. The synthesized molecules showed…”
    Get full text
    Journal Article
  5. 5

    The expanding repertoire of covalent warheads for drug discovery by Mehta, Namrashee V, Degani, Mariam S

    Published in Drug discovery today (01-12-2023)
    “…The reactive functionalities of drugs that engage in covalent interactions with the enzyme/receptor residue in either a reversible or an irreversible manner…”
    Get full text
    Journal Article
  6. 6

    Oxadiazole scaffolds in anti-tuberculosis drug discovery by De, Suparna S., Khambete, Mihir P., Degani, Mariam S.

    Published in Bioorganic & medicinal chemistry letters (15-08-2019)
    “…[Display omitted] With the increasing number of cases of latent and drug resistant tuberculosis, there is an urgent need to develop new, potent molecules…”
    Get full text
    Journal Article
  7. 7

    Elemental exchange: Bioisosteric replacement of phosphorus by boron in drug design by Mehta, Namrashee V., Abhyankar, Arundhati, Degani, Mariam S.

    Published in European journal of medicinal chemistry (15-11-2023)
    “…Continuous efforts are being directed toward the employment of boron in drug design due to its advantages and unique characteristics including a plethora of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Novel 2-hydrazino-pyrimidin-4(3H)-one derivatives with pseudofunctional- similarity to siderophores as potential antimycobacterial agents by Bairwa, Ranjeet, Tawari, Nilesh R, Alate, Amruta, Anam, Swapnil, Degani, Mariam S, Ray, Muktikant, Rajan, Ramakrishna M G

    “…Siderophores are small molecules produced by bacteria under iron-scarcity conditions faced by bacteria inside host. Sideophores bind iron with high affinity…”
    Get more information
    Journal Article
  10. 10

    Mutations in SARS‐CoV‐2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure by Reshamwala, Shamlan M. S., Likhite, Vishakha, Degani, Mariam S., Deb, Shalini S., Noronha, Santosh B.

    Published in Journal of medical virology (01-07-2021)
    “…Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) RNA‐dependent RNA polymerase (RdRp) has been identified to be a mutation hot spot, with the P323L…”
    Get full text
    Journal Article
  11. 11

    New Schiff Base-Linked Arylazopyrazoles as Reagents for the Photometric Detection of Fluoride Ions by Kumar, Manish, Agarkar, Harshawardhan, Degani, Mariam S.

    “…A novel class of reagents (L1–3) containing arylazopyrazole moiety linked to a Schiff base have been synthesized and investigated for anion sensing…”
    Get full text
    Journal Article
  12. 12

    Antimicrobial potential of quaternary phosphonium salt compounds: a review by Ibrahim, Mahin K, Haria, Akash, Mehta, Namrashee V, Degani, Mariam S

    Published in Future medicinal chemistry (01-11-2023)
    “…Given that mitochondrial dysregulation is a biomarker of many cancers, cationic quaternary phosphonium salt (QPS) conjugation is a widely utilized strategy for…”
    Get full text
    Journal Article
  13. 13

    Synthesis and in-vivo taste assessment of meloxicam pivalate by Chatale, Bandoo C., Degani, Mariam S.

    Published in Drug development and industrial pharmacy (03-10-2019)
    “…Meloxicam (MX), a nonsteroidal anti-inflammatory drug, widely used to treat arthritis, has a very bitter taste. Chemical modification of the bitter…”
    Get full text
    Journal Article
  14. 14

    Insights into the Interaction Mechanism of Ligands with Aβ42 Based on Molecular Dynamics Simulations and Mechanics: Implications of Role of Common Binding Site in Drug Design for Alzheimer's Disease by Kundaikar, Harish S., Degani, Mariam S.

    Published in Chemical biology & drug design (01-10-2015)
    “…Aggregation of β‐amyloid (Aβ) into oligomers and further into fibrils is hypothesized to be a key factor in pathology of Alzheimer's disease (AD). In this…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Pharmacophore based 3DQSAR of phenothiazines as specific human butyrylcholinesterase inhibitors for treatment of Alzheimer's disease by Kundaikar, Harish S, Agre, Neha P, Degani, Mariam S

    Published in Current computer-aided drug design (01-01-2014)
    “…Quantitative three dimensional structure activity relationship (3D-QSAR) studies were performed on phenothiazine derivatives as Butyrylcholinesterase (BuChE)…”
    Get more information
    Journal Article
  17. 17

    E84G mutation in dihydrofolate reductase from drug resistant strains of Mycobacterium tuberculosis (Mumbai, India) leads to increased interaction with Trimethoprim by Raju, Archana, Kulkarni, Savita, Ray, M.K, Rajan, M.G.R, Degani, Mariam S

    Published in International journal of mycobacteriology (01-06-2015)
    “…Abstract Background Dihydrofolate reductase (DHFR) ( dfrA gene) is an essential enzyme for cell survival and an unexplored target in Mycobacterium tuberculosis…”
    Get full text
    Journal Article
  18. 18

    Identification of a novel class of quinoline–oxadiazole hybrids as anti-tuberculosis agents by Jain, Puneet P., Degani, Mariam S., Raju, Archana, Anantram, Aarti, Seervi, Madhav, Sathaye, Sadhana, Ray, Muktikanta, Rajan, M.G.R.

    Published in Bioorganic & medicinal chemistry letters (15-01-2016)
    “…[Display omitted] A series of novel quinoline–oxadiazole hybrid compounds was designed based on stepwise rational modification of the lead molecules reported…”
    Get full text
    Journal Article
  19. 19

    Polyethylene Glycol Nitrite (PEG-ONO) as a Novel Diazotizing Agent by Bochare, Machhindra D, Degani, Mariam S

    Published in ACS sustainable chemistry & engineering (01-05-2017)
    “…A polyethylene glycol nitrite (PEG-ONO) has been developed as a novel diazotizing agent. It is found to be a cost-effective, highly stable, easy to handle, and…”
    Get full text
    Journal Article
  20. 20

    Antifolate Activity of Plant Polyphenols against Mycobacterium tuberculosis by Raju, Archana, Degani, Mariam S., Khambete, Mihir P., Ray, M. K., Rajan, M. G. R.

    Published in Phytotherapy research (01-10-2015)
    “…With the view of exploring phytochemicals as Mycobacterium tuberculosis (Mtb) dihydrofolate reductase inhibitors, known plant polyphenols from various classes…”
    Get full text
    Journal Article